Hattie Hayes is the editor of Ophthalmology Times Europe.
ASCRS 2024: Transforming how we think about IOL calculation with Light Adjustable Lens technology
Dr Neda Nikpoor discusses Light Adjustable Lenses and the implications for clinicians at ASCRS 2024
ASCRS 2024: International data are forthcoming in corneal endothelial disease treatment
At ASCRS 2024, Aurion Biotech's Global VP Eris Jordan previews upcoming clinical data from North America and Asia
ASCRS 2024: Comparing keratometry and total keratometry values in a large dataset
Jascha Wendelstein, MD, discusses the outcomes of a study comparing K and TK measurements
ASCRS 2024: What's new in the ESCRS IOL calculator?
At ASCRS 2024, Oliver Findl, MD, provides an update on the ESCRS IOL calculator and new tools to come this year
ASCRS 2024: At Eyecelerator, a New Zealand-based startup pitches eye drops for keratoconus
Ahead of the ASCRS 2024 meeting, TheiaNova CEO Carissa Fonseca, PhD, pitched a novel keratoconus treatment
ASCRS 2024: Surgical and pharmaceutical technology updates from Bausch + Lomb
At the 2024 ASCRS meeting, Anthony Wallace details the presentations and educational programmes from Bausch + Lomb
ASCRS 2024: Ease of opening arcuate incisions created with a dual pulse femtosecond laser
At the ASCRS meeting in Boston, Dan Tran, MD, details his presentation on incision quality and clinical outcomes of femtosecond laser
ASCRS 2024: 10-year results from a real-world study shed new light on glaucoma
At ASCRS in Boston, Paul Harasymowycz, MD shared a decade's worth of data on MIGS procedures for primary open-angle glaucoma
ASCRS 2024: Ultra-low cylinder powered toric versus non-toric lenses in cataract surgery
Adam Muzychuk, MD, BSc, FRCSC, discusses his ASCRS 2024 presentation on toric lens use for patients with low astigmatism
ASCRS 2024: Enrollment begins in Canada for cell therapy trial, targeting corneal endothelial disease
Greg Kunst, CEO of Aurion Biotech, discusses AURN001, a novel cell therapy targeting corneal endothelial disease
ASCRS 2024: Key features of LASIK using an updated laser ablation algorithm for myopia and myopic astigmatism
At ASCRS2024, George O. Waring IV, MD, FACS, provides an overview of his presentation highlighting outcomes for LASIK performed using an updated laser ablation algorithm
ESCRS president Filomena Ribeiro invites ASCRS attendees to 'cataract Olympiad' after successful Refractive Day
Filomena Ribeiro, MD, PhD, FEBO, discusses her presentation on neuroadaptation following the ASCRS Refractive Day
ASCRS 2024: CoFi integrates with CareCredit and marks participation milestone for ophthalmologists and optometrists
Sean Hanlon, CEO of CoFi, details the patient and provider benefits of recent CareCredit integration
ASCRS 2024: New Phase III study results and near-future plans for Neurotech and NT-501
Rich Small, CEO of Neurotech Pharmaceuticals, provides an update on the months ahead for NT-501 encapsulated cell therapy
Carl Zeiss Meditec AG announces completed acquisition of Dutch Ophthalmic Research Center
Zeiss has secured regulatory approvals to acquire DORC and will shift focus to integration implementation
Women in ophthalmology series: Ms Neeru A Vallabh gives advice for finding multiple mentors
The glaucoma specialist talks about navigating the world of research, and the realities of motherhood, as a clinician
Genetic editing untangles one strand of the AMD web
The opportunities and challenges presented by CRISPR manipulation
Outlook Therapeutics receives positive CHMP opinion for bevacizumab for wet age-related macular degeneration
The European Commission is expected to make a decision about the application before the end of June
COPHy 2024: Is artificial intelligence ready to replace physicians?
Retina specialists Giuseppe Querques, MD, PhD, and Paolo Lanzetta, MD, debate at the Congress on Controversies in Ophthalmology
COPHy 2024: How good are we really without artificial intelligence tools?
At this year's Congress on Controversies in Ophthalmology, keynote speaker Ursula Schmidt-Erfurth, MD, addressed the clinical use of artificial intelligence
Women in ophthalmology series: Dr Alexandra Miere encourages young ophthalmologists to step out of the comfort zone
The retina specialist shares advice for the clinician-scientists of a digital-centric future
Women in ophthalmology series: Dr Filomena Ribeiro on the importance of equity in education
Filomena Ribeiro, MD, PhD, FEBO, discusses the crucial role of mentors – and where to find them
United States FDA approves clobetasol propionate ophthalmic suspension 0.05% from Formosa Pharmaceuticals and AimMax Therapeutics
The approval marks the first new steroid on the US ophthalmic market in more than 15 years
AI models used to automate remote screening for diabetic retinopathy
The algorithms could provide major accessibility improvements and cost savings to underdeveloped regions
Sight Sciences announces European launch of OMNI Surgical System Ergo-Series
The company made its CE Mark announcement during the ESCRS Winter Meeting
Optica releases data on spiral diopter lens developed for multifocal vision correction
The technology has potential for applications in contact lenses and intraocular implants
UCL and Moorfields Eye Hospital receive £5 million toward eye health research facility Oriel
An investment from the Sir Jules Thorn Charitable Trust will support a state-of-the-art building, opening in 2027
Angiogenesis 2024: Targeting Ang2 and VEGF – Biology, Pharmacokinetics and Latest Clinical Data in nAMD and DME
Dr Jennifer Lim reveals new data on Angiopoietin-2 inhibition and insights on clinical trial design
Angiogenesis 2024: The implication of longitudinal AI-based fluid quantification for at-home monitoring
Anat Loewenstein, MD, illuminates the outcomes of using an AI-based fluid quantification for remote retina monitoring and analysis
Angiogenesis 2024: Findings from the DAVIO 2 trial, assessing EYP-1901 vs aflibercept for wet AMD
Dr Carl Regillo provided an overview of topline results – and a deep dive into subgroup analyses – of DAVIO 2 trial data